|
1
|
Mody MD, Rocco JW, Yom SS, Haddad RI and
Saba NF: Head and neck cancer. Lancet. 398:2289–2299. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Di Credico G, Polesel J, Dal Maso L, Pauli
F, Torelli N, Luce D, Radoï L, Matsuo K, Serraino D, Brennan P, et
al: Alcohol drinking and head and neck cancer risk: The joint
effect of intensity and duration. Br J Cancer. 123:1456–1463. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta I, Ghabreau L, Al-Thawadi H, Yasmeen
A, Vranic S, Al Moustafa AE and Malki MI: Co-incidence of human
papillomaviruses and Epstein-barr virus is associated with high to
intermediate tumor grade in human head and neck cancer in syria.
Front Oncol. 10:10162020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mourad M, Jetmore T, Jategaonkar AA,
Moubayed S, Moshier E and Urken ML: Epidemiological trends of head
and neck cancer in the united states: A SEER population study. J
Oral Maxillofac Surg. 75:2562–2572. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Economopoulou P, Kotsantis I, Kyrodimos E,
Lianidou ES and Psyrri A: Liquid biopsy: An emerging prognostic and
predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC).
Focus on Circulating Tumor Cells (CTCs). Oral Oncol. 74:83–89.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takes RP, Rinaldo A, Silver CE, Haigentz M
Jr, Woolgar JA, Triantafyllou A, Mondin V, Paccagnella D, de Bree
R, Shaha AR, et al: Distant metastases from head and neck squamous
cell carcinoma. Part I. Basic aspects. Oral Oncol. 48:775–779.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kopczyński P and Flieger R: Tumor markers
used in the diagnosis, monitoring, treatment, and prognosis head
and neck cancer. Pol Merkur Lekarski. 35:37–38. 2013.(In Polish).
PubMed/NCBI
|
|
9
|
Eskander A, Irish J, Groome PA, Freeman J,
Gullane P, Gilbert R, Hall SF, Urbach DR and Goldstein DP:
Volume-outcome relationships for head and neck cancer surgery in a
universal health care system. Laryngoscope. 124:2081–2088. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leipzig B, Zellmer JE and Klug D: The role
of endoscopy in evaluating patients with head and neck cancer. A
multi-institutional prospective study. Arch Otolaryngol.
111:589–594. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung CS, Lo WC, Wen MH, Hsieh CH, Lin YC
and Liao LJ: Long term outcome of routine Image-enhanced endoscopy
in newly diagnosed head and neck cancer: A prospective study of 145
patients. Sci Rep. 6:295732016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pantel K and Speicher MR: The biology of
circulating tumor cells. Oncogene. 35:1216–1224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Novel Biomarkers in the Continuum of
Breast Cancer. Anticancer Res. 36:32242016.
|
|
14
|
Shen Z, Wu A and Chen X: Current detection
technologies for circulating tumor cells. Chem Soci Rev.
46:2038–2056. 2017. View Article : Google Scholar
|
|
15
|
Bidard FC, Proudhon C and Pierga JY:
Circulating tumor cells in breast cancer. Mol Oncol. 10:418–430.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pantel K, Hille C and Scher HI:
Circulating tumor cells in prostate cancer: From discovery to
clinical utility. Clin Chem. 65:87–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia S, Zhang R, Li Z and Li J: Clinical
and biological significance of circulating tumor cells, circulating
tumor DNA, and exosomes as biomarkers in colorectal cancer.
Oncotarget. 8:55632–55645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong M, Luo S, Gu L, Wang X, Zhang Z,
Liang C, Huang H, Lin Y and Huang J: SIMarker: Cellular similarity
detection and its application to diagnosis and prognosis of liver
cancer. Comput Biol Med. 171:1081132024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ramirez JM, Fehm T, Orsini M, Cayrefourcq
L, Maudelonde T, Pantel K and Alix-Panabières C: Prognostic
relevance of viable circulating tumor cells detected by EPISPOT in
metastatic breast cancer patients. Clin Chem. 60:214–221. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin D, Shen L, Luo M, Zhang K, Li J, Yang
Q, Zhu F, Zhou D, Zheng S, Chen Y and Zhou J: Circulating tumor
cells: Biology and clinical significance. Signal Transduct Target
Ther. 6:4042021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coumans F and Terstappen L: Detection and
characterization of circulating tumor cells by the cellsearch
approach. Methods Mol Biol. 1347:263–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rheinländer A, Schraven B and Bommhardt U:
CD45 in human physiology and clinical medicine. Immunol Lett.
196:22–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alix-Panabières C and Pantel K: Challenges
in circulating tumour cell research. Nat Rev Cancer. 14:623–631.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alix-Panabières C and Pantel K:
Circulating tumor cells: Liquid biopsy of cancer. Clin Chem.
59:110–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng Z, Wu S, Wang Y and Shi D:
Circulating tumor cell isolation for cancer diagnosis and
prognosis. EBioMedicine. 83:1042372022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pereira-Veiga T, Schneegans S, Pantel K
and Wikman H: Circulating tumor cell-blood cell crosstalk: Biology
and clinical relevance. Cell Rep. 40:1112982022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu M, Stott S, Toner M, Maheswaran S and
Haber DA: Circulating tumor cells: Approaches to isolation and
characterization. J Cell Biol. 192:373–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park CH, Lee JI, Sung J, Choi S and Ko KP:
A flow visualization model of duodenogastric reflux after
esophagectomy with gastric interposition. J Cardiothorac Surg.
8:1922013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Xiao Y, Zhao J, Chen M, Xu Y,
Zhong W, Xing J and Wang M: Relationship between circulating tumour
cell count and prognosis following chemotherapy in patients with
advanced non-small-cell lung cancer. Respirology. 21:519–525. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nieva J, Wendel M, Luttgen MS, Marrinucci
D, Bazhenova L, Kolatkar A, Santala R, Whittenberger B, Burke J,
Torrey M, et al: High-definition imaging of circulating tumor cells
and associated cellular events in non-small cell lung cancer
patients: A longitudinal analysis. Phys Biol. 9:0160042012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nichols AC, Lowes LE, Szeto CC, Basmaji J,
Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond
A, et al: Detection of circulating tumor cells in advanced head and
neck cancer using the CellSearch system. Head Neck. 34:1440–1444.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bozec A, Ilie M, Dassonville O, Long E,
Poissonnet G, Santini J, Chamorey E, Ettaiche M, Chauvière D,
Peyrade F, et al: Significance of circulating tumor cell detection
using the CellSearch system in patients with locally advanced head
and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol.
270:2745–2749. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Buglione M, Grisanti S, Almici C, Mangoni
M, Polli C, Consoli F, Verardi R, Costa L, Paiar F, Pasinetti N, et
al: Circulating tumour cells in locally advanced head and neck
cancer: Preliminary report about their possible role in predicting
response to non-surgical treatment and survival. Eur J Cancer.
48:3019–3026. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guney K, Yoldas B, Ozbilim G, Derin AT,
Sarihan S and Balkan E: Detection of micrometastatic tumor cells in
head and neck squamous cell carcinoma. A possible predictor of
recurrences? Saudi Med J. 28:216–220. 2007.PubMed/NCBI
|
|
35
|
Li H, Li B, Pan Y, Zhang Y, Xiang J, Zhang
Y, Sun Y, Yu X, He W and Hu H: Preoperative folate
receptor-positive circulating tumor cell level is a prognostic
factor of long term outcome in non-small cell lung cancer patients.
Front Oncol. 10:6214352020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bertamini L and Oliva S: High levels of
circulating tumor plasma cells as a key hallmark of aggressive
disease in Transplant-Eligible patients with newly diagnosed
multiple myeloma. J Clin Oncol. 40:3120–3131. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ju L, Yang J, Zhai C, Chai S, Dong Z and
Li M: Survival, Chemotherapy and Chemosensitivity Predicted by CTC
Cultured In Vitro of SCLC Patients. Front Oncol. 11:6833182021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Martin OA, Anderson RL, Russell PA, Cox
RA, Ivashkevich A, Swierczak A, Doherty JP, Jacobs DH, Smith J,
Siva S, et al: Mobilization of viable tumor cells into the
circulation during radiation therapy. Int J Radiat Oncol Biol Phys.
88:395–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Morosin T, Ashford B, Ranson M, Gupta R,
Clark J, Iyer NG and Spring K: Circulating tumour cells in
regionally metastatic cutaneous squamous cell carcinoma: A pilot
study. Oncotarget. 7:47111–47115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Balasubramanian P, Lang JC, Jatana KR,
Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers
TA Jr, et al: Multiparameter analysis, including EMT markers, on
negatively enriched blood samples from patients with squamous cell
carcinoma of the head and neck. PLoS One. 7:e420482012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dorsey JF, Kao GD, MacArthur KM, Ju M,
Steinmetz D, Wileyto EP, Simone CB II and Hahn SM: Tracking viable
circulating tumor cells (CTCs) in the peripheral blood of non-small
cell lung cancer (NSCLC) patients undergoing definitive radiation
therapy: Pilot study results. Cancer. 121:139–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jatana KR, Balasubramanian P, Lang JC,
Yang L, Jatana CA, White E, Agrawal A, Ozer E, Schuller DE, Teknos
TN and Chalmers JJ: Significance of circulating tumor cells in
patients with squamous cell carcinoma of the head and neck: Initial
results. Arch Otolaryngol Head Neck Surg. 136:1274–1279. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Winter SC, Stephenson SA, Subramaniam SK,
Paleri V, Ha K, Marnane C, Krishnan S and Rees G: Long term
survival following the detection of circulating tumour cells in
head and neck squamous cell carcinoma. BMC Cancer. 9:4242009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jatana KR, Balasubramanian P, McMullen KP,
Lang JC, Teknos TN and Chalmers JJ: Effect of surgical intervention
on circulating tumor cells in patients with squamous cell carcinoma
of the head and neck using a negative enrichment technology. Head
Neck. 38:1799–1803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao W, Li JZ, Ho WK, Chan JY and Wong TS:
Biomarkers for use in monitoring responses of nasopharyngeal
carcinoma cells to ionizing radiation. Sensors (Basel).
12:8832–8846. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tinhofer I, Hristozova T, Stromberger C,
Keilhoiz U and Budach V: Monitoring of circulating tumor cells and
their expression of EGFR/phospho-EGFR during combined radiotherapy
regimens in locally advanced squamous cell carcinoma of the head
and neck. Int J Radiat Oncol Biol Phys. 83:e685–e690. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jatana KR, Lang JC and Chalmers JJ:
Identification of circulating tumor cells: A prognostic marker in
squamous cell carcinoma of the head and neck? Future Oncol.
7:481–484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Schochter F, Friedl TWP, deGregorio A,
Krause S, Huober J, Rack B and Janni W: Are Circulating tumor cells
(CTCs) ready for clinical use in breast cancer? An overview of
completed and ongoing trials using CTCs for clinical treatment
decisions. Cells. 8:14122019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kyrodimos E, Chrysovergis A, Mastronikolis
N, Tsiambas E, Ragos V, Roukas D, Fotiades P and Papanikolaou V:
Targeting EGFR in nasopharyngeal carcinoma. J BUON. 26:759–761.
2021.PubMed/NCBI
|
|
50
|
Aguayo F, Perez-Dominguez F and Osorio JC:
PI3K/AKT/mTOR signaling pathway in HPV-Driven head and neck
carcinogenesis: Therapeutic implications. Biology (Basel).
12:6722023.PubMed/NCBI
|
|
51
|
O'Meara CH and Jafri Z: Immune checkpoint
inhibitors, Small-molecule immunotherapies and the emerging role of
neutrophil extracellular traps in therapeutic strategies for head
and neck cancer. Int J Mol Sci. 24:116952023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bao Y, Gabrielpillai J, Dietrich J, Zarbl
R, Strieth S, Schröck F and Dietrich D: Fibroblast growth factor
(FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation
in head and neck squamous cell carcinomas is associated with
transcriptional activity, gene amplification, human papillomavirus
(HPV) status, and sensitivity to tyrosine kinase inhibitors. Clin
Epigenetics. 13:2282021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Khadela A, Shah Y, Mistry P, Mansuri M,
Sureja D and Bodiwala K: A review of efficacy and safety of
cetuximab and bevacizumab-based monoclonal antibodies in head and
neck cancer. Med Oncol. 40:662022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cierpikowski P, Leszczyszyn A and Bar J:
The role of hedgehog signaling pathway in head and neck squamous
cell carcinoma. Cells. 12:20832023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tsimberidou AM, Fountzilas E, Nikanjam M
and Kurzrock R: Review of precision cancer medicine: Evolution of
the treatment paradigm. Cancer Treat Rev. 86:1020192020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
de Wit S, van Dalum G and Terstappen LW:
Detection of circulating tumor cells. Scientifica (Cairo).
2014:8193622014.PubMed/NCBI
|
|
57
|
Hoeppener AE, Swennenhuis JF and
Terstappen LW: Immunomagnetic separation technologies. Recent
Results Cancer Res. 195:43–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hanna GJ, Patel N, Tedla SG, Baugnon KL,
Aiken A and Agrawal N: Personalizing surveillance in head and neck
cancer. Am Soc Clin Oncol Educ Book. 43:e3897182023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Huang X, Duijf PHG, Sriram S, Perera G,
Vasani S, Kenny L, Leo P and Punyadeera C: Circulating tumour DNA
alterations: Emerging biomarker in head and neck squamous cell
carcinoma. J Biomed Sci. 30:652023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tsutsuyama M and Nakanishi H: Detection of
circulating tumor cells in drainage venous blood from colorectal
cancer patients using a new filtration and cytology-based automated
platform. PLoS One. 14:e02122212019. View Article : Google Scholar : PubMed/NCBI
|
